CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pernix Ireland Pain Ltd. v. Actavis Laboratories FL, Inc.

1:16-cv-00138

Overview

Case Number 1:16-cv-00138
Filing Date 2016-03-04
Status Terminated
Termination Date 2018-01-30
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Defendant

Actavis Laboratories FL, Inc. Operating Company

Represented By

8 Attorneys Listed

Thomas J. Meloro

Email: tmeloro@willkie.com

Selena E. Molina

Delaware Court of Chancery

Tel: +1 (302) 421-6829

Delaware Court of Chancery, 500 North King Street

Scott J. Bornstein

Email: bornsteins@gtlaw.com

Richard C. Pettus

Email: pettusr@gtlaw.com

Jonathan D. Ball

Email: ballj@gtlaw.com

Heather M. Schneider

Email: hschneider@willkie.com

Douglas R. Weider

Email: weiderd@gtlaw.com

Kelly E. Farnan

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7705

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Pernix Therapeutics, LLC Operating Company

Represented By

4 Attorneys Listed

David G. Varghese

UNDELIVERABLE EMAIL 4/10/2019

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Pernix Ireland Pain Ltd. Operating Company

Represented By

8 Attorneys Listed

Josh Calabro

Email: jcalabro@fchs.com

David G. Varghese

UNDELIVERABLE EMAIL 4/10/2019

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Christopher J. Stankus

Email: cstankus@fchs.com

Christopher P. Borello

Email: cborello@venable.com

Brendan M. O'Malley

UNDELIVERABLE EMAIL 8/14/2019

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 16 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (16): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

6 Patents

There are 6 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9265760
Treating pain in patients with hepatic impairment
Filed: 2015-07-31
Issued: 2016-02-23
Active (8.7 yrs remaining)
Expires: 2035-07-31
US9326982
Treating pain in patients with hepatic impairment
Filed: 2015-12-22
Issued: 2016-05-03
Active (9.1 yrs remaining)
Expires: 2035-12-22
US9333201
Treating pain in patients with hepatic impairment
Filed: 2015-12-22
Issued: 2016-05-10
Active (9.1 yrs remaining)
Expires: 2035-12-22
US9339499
Treating pain in patients with hepatic impairment
Filed: 2015-12-22
Issued: 2016-05-17
Active (9.1 yrs remaining)
Expires: 2035-12-22
US9421200
Treating pain in patients with hepatic impairment
Filed: 2016-05-13
Issued: 2016-08-23
Active (9.5 yrs remaining)
Expires: 2036-05-13

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

51

Dispositive

14

Granted

0

Denied

0

Pending / Review

33

Motions by Category

Procedural / Extension Motion 26 Motion to Dismiss (FRCP 12(b)(6)) 10 Motion to Dismiss 3 Motion for Preliminary Injunction / TRO 1 Claim Construction / Markman Filing 11

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending
Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 10/18/2016. The Court adopted the parties' proposal an...
Entry #— • 2016-10-18
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
REPLY BRIEF re 27 MOTION to Dismiss for Failure to State a Claim filed by Actavis Laboratories FL, Inc.. (Farnan, Kelly) Modified on 7/20/2016 (mdb). (Entered: ...
Entry #33 • 2016-07-11 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
ANSWERING BRIEF in Opposition re 27 MOTION to Dismiss for Failure to State a Claim filed by Pernix Ireland Pain Ltd., Pernix Therapeutics, LLC.Reply Brief due d...
Entry #29 • 2016-07-01 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
MOTION to Dismiss for Failure to State a Claim - filed by Actavis Laboratories FL, Inc.. (Attachments: # 1 Text of Proposed Order)(Farnan, Kelly) (Entered: 06/1...
Entry #27 • 2016-06-17 Document →
Motion to Dismiss (FRCP 12(b)(6)) Pending / Under Review
OPENING BRIEF in Support re 27 MOTION to Dismiss for Failure to State a Claim filed by Actavis Laboratories FL, Inc..Answering Brief/Response due date per Local...
Entry #28 • 2016-06-17 Document →
Motion to Dismiss Pending
SO ORDERED - re (20 in 1:16-cv-00139-GMS, 20 in 1:16-cv-00138-GMS) STIPULATION TO EXTEND TIME for Defendants to File a Reply Brief in Support of the Motion to D...
Entry #— • 2016-05-25

Docket Entries

(224 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Actavis Laboratories FL, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1889560.) - filed by Pernix Ireland Pain Ltd., Pernix Therapeutics, LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 03/07/2016)

Entry #1 • 2016-03-04
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Actavis Laboratories FL, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1889560.) - filed by Pernix Ireland Pain Ltd., Pernix Therapeutics, LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 03/07/2016)

Entry #1 • 2016-03-04
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Actavis Laboratories FL, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1889560.) - filed by Pernix Ireland Pain Ltd., Pernix Therapeutics, LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 03/07/2016)

Entry #1 • 2016-03-04
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 03/07/2016)

Entry #2 • 2016-03-04
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 7/23/2033.Thirty Month Stay Deadline: 2/12/2017. (nmb) (Entered: 03/07/2016)

Entry #3 • 2016-03-04
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc